Zobrazeno 1 - 10
of 69
pro vyhledávání: '"T. Reshetnyak"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/90bc55017a4748b3839665ef209cb647
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/efb88ce37e0841119b37cde00ee815ab
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/8fd18907536f4fa39bf6f825ebc3d815
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Publikováno v:
Annals of the Rheumatic Diseases. 81:1188.1-1189
BackgroundThromboinflammation is a pathological process that is associated with uncontrolled inflammation, leading to hypercoagulability and thrombotic complications. Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are prototyp
Publikováno v:
Annals of the Rheumatic Diseases. 81:1750.1-1750
BackgroundIn Behcet’s Disease (BD) some major organs are more involved in men and have worse outcomes. Gender related clinical features of BD are different in various countries.Objectivesto describe the gender related clinical features of Russian F
Publikováno v:
Annals of the Rheumatic Diseases. 81:1390.2-1391
BackgroundSystemic lupus erythematosus (SLE) is a heterogeneous chronic autoimmune rheumatic disease with a wide range of clinical manifestations, characterized by impaired activation of cellular and humoral links of immunity, uncontrolled hyperprodu
Publikováno v:
Annals of the Rheumatic Diseases. 81:670.1-670
BackgroundThe study of other non-criteria antiphospholipid antibodies (aPL) may improve the stratification of patients with antiphospholipid syndrome (APS) and assist in the interpretation of conflicting results on aPL testing.ObjectivesTo determine